Trademark: 77633128
Word

Status
Dead
Status Code
606
Status Date
Monday, August 6, 2012
Serial Number
77633128
Mark Type
2000
Filing Date
Monday, December 15, 2008
Published for Opposition
Tuesday, April 14, 2009
Abandoned Date
Monday, August 6, 2012

Trademark Owner History
Cadence Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use, namely, analgesic and antipyretic preparations
Color is not claimed as a feature of the mark.
The mark consists of Dots in the general shape of a "V".

Trademark Events
Aug 6, 2012
Abandonment Notice Mailed - No Use Statement Filed
Aug 6, 2012
Abandonment - No Use Statement Filed
May 23, 2012
Attorney Revoked And/Or Appointed
May 23, 2012
Teas Revoke/Appoint Attorney Received
Jan 10, 2012
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2012
Extension 5 Granted
Dec 29, 2011
Extension 5 Filed
Dec 29, 2011
Teas Extension Received
Oct 27, 2011
Assigned To Examiner
Jul 12, 2011
Notice Of Approval Of Extension Request E-Mailed
Jul 11, 2011
Extension 4 Granted
Jul 6, 2011
Extension 4 Filed
Jul 6, 2011
Teas Extension Received
May 6, 2011
Teas Change Of Correspondence Received
Dec 14, 2010
Notice Of Approval Of Extension Request E-Mailed
Dec 13, 2010
Extension 3 Granted
Dec 9, 2010
Extension 3 Filed
Dec 9, 2010
Teas Extension Received
Jul 13, 2010
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2010
Extension 2 Granted
Jun 14, 2010
Extension 2 Filed
Jul 12, 2010
Case Assigned To Intent To Use Paralegal
Jun 14, 2010
Teas Extension Received
Dec 2, 2009
Extension 1 Granted
Dec 2, 2009
Extension 1 Filed
Dec 2, 2009
Teas Extension Received
Jul 7, 2009
Noa Mailed - Sou Required From Applicant
Apr 14, 2009
Published For Opposition
Mar 25, 2009
Notice Of Publication
Mar 11, 2009
Law Office Publication Review Completed
Mar 11, 2009
Assigned To Lie
Mar 11, 2009
Approved For Pub - Principal Register
Mar 11, 2009
Assigned To Examiner
Dec 19, 2008
Notice Of Design Search Code Mailed
Dec 18, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24